CriticalThinkRx May Reduce Psychiatric Prescribing to Foster Youth: Results From an Intervention Trial

Research on Social Work Practice

Volumn 23, Issue 3, 2013, Pages 284-293

  Cohen, David ^a   Lacasse, Jeffrey R ^b   Duan, Rui ^c   Sengelmann, Inge ^d  

^a FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d The Counseling Group   (United States)

Author keywords

child welfare; children; education; field of practice; foster care; intervention; mental health; outcome study; population; program evaluation; quasi experiment

Indexed keywords

EID: 84876059488     PISSN: 10497315     EISSN: 15527581     Source Type: Journal    
DOI: 10.1177/1049731513477691     Document Type: Article

References (36)

1. Alexander G. C.,Gallagher S. A.,Mascola A.,Moloney R. M.,Stafford R. S.Increasing off-label use of antipsychotic medications in the United States, 1995-2008.Pharmacoepidemiology and Drug Safety. 2011;20:177-184.
2. Diagnostic and statistical manual of mental disorders. 2000). Diagnostic and statistical manual of mental disorders (4th ed., Text Rev). Washington, DC: Author.Washington, DC: Author; 2000:.
3. Report of the Working Group on Psychoactive Medications for Children and Adolescents. Psychopharmacological, psychosocial, and combined interventions for childhood disorders: Evidence base, contextual factors, and future directions. Washington, DC: American Psychological Association; 2006:.
4. Baandrup L.,Allerup P.,Lublin H.,Nordentoft M.,Peackock L.,Glenthoj B.Evaluation of a multifaceted intervention to limit excessive antipsychotic co-prescribing in schizophrenia out-patients.Acta Psychiatrica Scandinavica. 2010;122:367-374.
5. Babbie E. R.The basics of social research. 2008). The basics of social research (5th ed.). Belmont, CA: Thomson/Wadsworth.Belmont, CA: Thomson/Wadsworth; 2008:.
6. Chua S. E.,Deng Y.,Chen E. Y. H.,Law C. W.,Chiu C. P. Y.,Cheung C.McAlonan G. M.Early striatal hypertrophy in first-episode psychosis within 3 weeks of initiating antipsychotic drug therapy.Psychological Medicine. 2009;39:793-800.
7. Cohen D.Critical new perspectives on ADHD. Lloyd G.Stead J.Cohen D., ed. New York, NY: Routledge; 2006:131-155.
8. CohenD.SengelmannI. (2008). CriticalThinkRx: A critical curriculum on psychotropic medications. Retrieved fromwww.criticalthinkrx.org.
9. Correll C. U.,Manu P.,Olshanskiy V.,Napolitano B.,Kane J. M.,Malhotra A. K.Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents.Journal of American Medical Association. 2009;302:1765-1773.
10. Dunning T.Improving causal inference: Strengths and limitations of natural experiments.Political Research Quarterly. 2008;61:282-293.
11. Dunning T.Rethinking social inquiry: Diverse tools, shared standards. 2010). Design-based inference: Beyond the pitfalls of regression analysis? In CollierD.BradyH. (Eds.), Rethinking social inquiry: Diverse tools, shared standards (2nd ed., pp. 273-311). Lanham, MD: Rowman & Littlefield.Collier D.Brady H., ed. Lanham, MD: Rowman & Littlefield; 2010:273-311.
12. Freedman D. A.Statistical models and shoe leather.Sociological Methodology. 1991;21:291-313.
13. Government Accountability Office. (2011). HHS guidance could help states improve oversight of psychotropic medications. Retrieved fromhttp://www.gao.gov/assets/590/586570.pdf.
14. Gomory T.,Wong S. E.,Cohen D.,Lacasse J. R.Clinical social work and the biomedical industrial complex.Journal of Sociology & Social Welfare. 2011;38:135-165.
15. Healy D.Pharmaggedon. Berkeley: University of California Press; 2012:.
16. Ho B.-C.,Andreasen N. C.,Ziebell S.,Pierson R.,Magnotta V.Long-term antipsychotic treatment and brain volumes: A longitudinal study of first-episode schizophrenia.Archives of General Psychiatry. 2011;68:128-137.
17. HundleyK. (2009, March 29). Approval process lowers the number of kids on atypical prescriptions. St. Petersburg Times. Retrieved fromhttp://www.tampabay.com/news/health/article987612.ece.
18. Jacobs E. S.,Dickstein D. P.,Libelt E. L.Novel psychotropic medications in children: New toxicities to master.Pediatric Emergency Care. 2001;17:226-231.
19. Jerrell J. M.,McIntyre R. S.Adverse events in children and adolescents treated with antipsychotic medications.Human Psychopharmacology: Clinical and Experimental. 2008;23:283-290.
20. LaforgiaM. (2011, May 22). Drugging juveniles: Doctors hired to evaluate kids in state custody have taken huge payments from drug companies. The Palm Beach Post(Florida). Retrieved fromhttp://www.palmbeachpost.com.
21. Landsverk J. A.,Burns B. J.,Stambough L. F.,Rentz J. A. R.Psychosocial interventions for children and adolescents in foster care: Review of research literature.Child Welfare. 2009;88:49-69.
22. Leslie L. K.,Raghavan R.,Zhang J.,Aarons G. A.Rates of psychotropic medication use over time among children in child welfare/child protective services.Journal of Child and Adolescent Psychopharmacology. 2010;20:135-143.
23. Midkiff D. M.,Wyatt W. J.Has behavioral science tumbled through the biological looking glass? Will brief, evidence-based training return it from the rabbit hole?.Behavior and Social Issues. 2010;19:46-77.
24. Raghavan R.,Lama G.,Kohl P.,Hamilton B.Interstate variations in psychotropic medication use among a national sample of children in the child welfare system.Child Maltreatment. 2010;15:121-131.
25. Raghavan R.,Zima B. T.,Andersen R. M.,Leibowitz A. A.,Schuster M. A.,Landsverk J.Psychotropic medication use in a national probability sample of children in the child welfare system.Journal of Child and Adolescent Psychopharmacology. 2005;15:97-106.
26. SAS/STAT9.2: User' s guide. 2010). SAS/STAT9.2: User' s guide (2nd ed.). Cary, NC: Author.Cary, NC: Author; 2010:.
27. SAS Tech Support. (2011, June 14). Usage note 43522: Fitting truncated poisson and negative binomial models. Retrieved fromhttp://support.sas.com/kb/43/522.html.
28. Singer J. D.,Willett J. B.Applied longitudinal data analysis: Modeling change and event occurrence. New York, NY: Oxford University Press; 2003:.
29. Sparks J.,Duncan B.,Cohen D.,Antonuccio D.The heart and soul of change: Delivering what works. 2010). Psychiatric drugs and common factors: An evaluation of risks and benefits for clinical practice. In DuncanB.MillerS.WampoldB.HubbleM. (Eds.), The heart and soul of change: Delivering what works (2nd ed., pp. 199-235). Washington, DC: American Psychological Association.Duncan B.Miller S.Wampold B.Hubble M., ed. Washington, DC: American Psychological Association; 2010:199-235.
30. StenslieM. (2008, May 8). Response by Misty Stenslie, MSW, Fostercare Alumni of America deputy director. Public Congressional hearing on psychotropic drug use among children in foster care. Retrieved fromhttp://www.fostercarealumni.org.
31. Varley C. K.,McClellan J.Implications of marked weight gain associated with atypical antipsychotic mediations in children and adolescents.Journal of American Medical Association. 2009;302:1811-1812.
32. Weissman E. M.Antipsychotic prescribing practices in the Veterans Healthcare Administration-New York metropolitan region.Schizophrenia Bulletin. 2002;28:31-42.
33. Westbury J.,Jackson S.,Gee P.,Peterson G.An effective approach to decrease antipsychotic and benzodiazepine use in nursing homes: The RedUSe project.International Psychogeriatrics. 2010;22:26-36.
34. Whisman M. A.The efficacy of booster maintenance sessions in behavior therapy: Review and methodological critique.Clinical Psychology Review. 1990;10:155-170.
35. Ziliak S. T.,McCloskey D. N.The cult of significance: How the standard error costs us jobs, justice, and lives. Ann Arbor: University of Michigan; 2008:.
36. Zito J. M.,Derivan A. T.,Kratochvil C. J.,Safer D. J.,Fegert J. M.,Greenhill L. L.Off-label psychopharmacologic prescribing for children: History supports close clinical monitoring.Child and Adolescent Psychiatry and Mental Health. 2008;2:24-24.